Effect of nadroparin on anti-Xa activity during nocturnal hemodialysis

por Buitenwerf, Edward, Risselada, Arne J., van Roon, Eric N., Veeger, Nic J.G.M., Hemmelder, Marc H.
Publicado 2015

Direct treatment comparison of DAbigatran and RIvaroxaban versus NAdroparin in the prevention of venous thromboembolism after total knee arthroplasty surgery: design of a randomise...

por van Veen, Lucia, van Raay, Jos JAM, Gerritsma-Bleeker, Carina L E, Veeger, Nic JGM, van Hulst, Marinus
Publicado 2013

Bleeding complications of thromboprophylaxis with dabigatran, nadroparin or rivaroxaban for 6 weeks after total knee arthroplasty surgery: a randomised pilot study

por van der Veen, Lucia, Segers, Marijn, van Raay, Jos JAM, Gerritsma-Bleeker, Carina LE, Brouwer, Reinoud W, Veeger, Nic JGM, van Hulst, Marinus
Publicado 2021

Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients

por van der Helm, Lieke H, Scheepers, Ellen RM, Veeger, Nic JGM, Daenen, Simon MGJ, Mulder, André B, van den Berg, Eva, Vellenga, Edo, Huls, Gerwin
Publicado 2013

Case Series about the Changed Antiplatelet Protocol for Carotid Endarterectomy in a Teaching Hospital: More Patients with Complications?

por Marsman, Martijn S., Özdemir- van Brunschot, Denise M.D., Jahrome, Abdelkarime Kh, Veeger, Nic J.G.M., Schuiling, Wouter J., van Rooij, Frank G., Koning, Giel G.
Publicado 2018

Effectiveness and safety of dabigatran versus acenocoumarol in ‘real-world’ patients with atrial fibrillation

por Korenstra, Jennie, Wijtvliet, E. Petra J., Veeger, Nic J.G.M., Geluk, Christiane A., Bartels, G. Louis, Posma, Jan L., Piersma-Wichers, Margriet, Van Gelder, Isabelle C., Rienstra, Michiel, Tieleman, Robert G.
Publicado 2016